ImportRefusal LogoImportRefusal

ELIPESA Farmaceutica

⚠️ Moderate Risk

FEI: 3003694757 • Santo Domingo • DOMINICAN REPUBLIC

FEI

FEI Number

3003694757

📍

Location

Santo Domingo

🇩🇴
🏢

Address

Ave 27 de Feb , esq. Isabel Aguiar, Zona Industrial de herrera, Santo Domingo, , Dominican Republic

Moderate Risk

FDA Import Risk Assessment

41.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
1
Unique Violations
9/16/2011
Latest Refusal
7/25/2006
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
3.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
9/16/2011
54ABY99VITAMIN, N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/25/2006
62FCY03NITROFURAZONE
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is ELIPESA Farmaceutica's FDA import refusal history?

ELIPESA Farmaceutica (FEI: 3003694757) has 2 FDA import refusal record(s) in our database, spanning from 7/25/2006 to 9/16/2011.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ELIPESA Farmaceutica's FEI number is 3003694757.

What types of violations has ELIPESA Farmaceutica received?

ELIPESA Farmaceutica has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ELIPESA Farmaceutica come from?

All FDA import refusal data for ELIPESA Farmaceutica is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.